[go: up one dir, main page]

BR9908472B1 - Processo para a preparação de um composto aminometil-pirrolidina-3-ona protegido, e, composto - Google Patents

Processo para a preparação de um composto aminometil-pirrolidina-3-ona protegido, e, composto

Info

Publication number
BR9908472B1
BR9908472B1 BRPI9908472-4B1A BR9908472A BR9908472B1 BR 9908472 B1 BR9908472 B1 BR 9908472B1 BR 9908472 A BR9908472 A BR 9908472A BR 9908472 B1 BR9908472 B1 BR 9908472B1
Authority
BR
Brazil
Prior art keywords
aminometil
pyrolidine
protected
preparation
ona compound
Prior art date
Application number
BRPI9908472-4B1A
Other languages
English (en)
Other versions
BRPI9908472B8 (pt
BR9908472A (pt
Inventor
Kwang Yul Moon
Won Sup Kim
Tae Hee Lee
Jay Hyok Chang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9908472A publication Critical patent/BR9908472A/pt
Publication of BR9908472B1 publication Critical patent/BR9908472B1/pt
Publication of BRPI9908472B8 publication Critical patent/BRPI9908472B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI9908472A 1998-03-04 1999-03-04 processo para a preparação de um composto aminometil-pirrolidina-3-ona protegido, e, composto BRPI9908472B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19980007079 1998-03-04
KR1019980043636A KR100286874B1 (ko) 1998-03-04 1998-10-19 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
PCT/KR1999/000099 WO1999044991A1 (en) 1998-03-04 1999-03-04 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one

Publications (3)

Publication Number Publication Date
BR9908472A BR9908472A (pt) 2000-12-05
BR9908472B1 true BR9908472B1 (pt) 2013-11-05
BRPI9908472B8 BRPI9908472B8 (pt) 2021-05-25

Family

ID=26633492

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9908472A BRPI9908472B8 (pt) 1998-03-04 1999-03-04 processo para a preparação de um composto aminometil-pirrolidina-3-ona protegido, e, composto

Country Status (29)

Country Link
US (1) US6307059B1 (pt)
EP (1) EP1068182B1 (pt)
JP (1) JP3374155B2 (pt)
KR (1) KR100286874B1 (pt)
CN (1) CN1149192C (pt)
AP (1) AP1305A (pt)
AT (1) ATE297379T1 (pt)
AU (1) AU742497B2 (pt)
BG (1) BG64674B1 (pt)
BR (1) BRPI9908472B8 (pt)
CA (1) CA2322540C (pt)
CZ (1) CZ301011B6 (pt)
DE (1) DE69925721T2 (pt)
EA (1) EA002499B1 (pt)
ES (1) ES2242382T3 (pt)
HU (1) HU228309B1 (pt)
ID (1) ID25901A (pt)
IL (1) IL137828A0 (pt)
IN (1) IN190979B (pt)
IS (1) IS2296B (pt)
NO (1) NO317258B1 (pt)
NZ (2) NZ506312A (pt)
OA (1) OA11482A (pt)
PT (1) PT1068182E (pt)
SK (1) SK285595B6 (pt)
TR (3) TR200101800T2 (pt)
TW (1) TW453993B (pt)
UA (1) UA71907C2 (pt)
WO (1) WO1999044991A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
KR20020018560A (ko) * 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법
ES2314082T3 (es) * 2001-08-02 2009-03-16 Lg Life Sciences Limited Procedimientos para la produccion de derivados amino protegidos de 4-aminometilenpirrolidin-3-ona, gemifloxacina y sus sales.
IL160708A0 (en) * 2001-09-26 2004-08-31 Bayer Pharmaceuticals Corp 1, 6-naphthyridine derivatives as antidiabetics
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100515591B1 (ko) * 2003-02-12 2005-09-16 주식회사 엘지화학 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
DE102004010943A1 (de) * 2004-03-03 2005-09-29 Degussa Ag Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten
US7185495B2 (en) * 2004-09-07 2007-03-06 General Electric Company System and method for improving thermal efficiency of dry low emissions combustor assemblies
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法
CN106349083A (zh) * 2016-08-26 2017-01-25 大连奇凯医药科技有限公司 2,4,6‑三氟苯甲胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN113773240B (zh) * 2021-10-12 2022-05-31 北京阳光诺和药物研究股份有限公司 吉米沙星侧链化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309368A (en) * 1965-11-19 1967-03-14 American Cyanamid Co Substituted isoxazoles and methods of preparing the same
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
JPH0673056A (ja) * 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
EP0688772B1 (en) * 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation

Also Published As

Publication number Publication date
NO20004288D0 (no) 2000-08-25
EP1068182B1 (en) 2005-06-08
TW453993B (en) 2001-09-11
NZ516778A (en) 2002-12-20
AP1305A (en) 2004-09-10
IS2296B (is) 2007-10-15
HUP0101094A3 (en) 2001-11-28
CN1291975A (zh) 2001-04-18
PT1068182E (pt) 2005-10-31
CZ20003109A3 (cs) 2001-07-11
UA71907C2 (uk) 2005-01-17
TR200002526T2 (tr) 2001-03-21
AU742497B2 (en) 2002-01-03
BRPI9908472B8 (pt) 2021-05-25
KR100286874B1 (ko) 2001-04-16
BG64674B1 (bg) 2005-11-30
NO317258B1 (no) 2004-09-27
DE69925721D1 (de) 2005-07-14
NO20004288L (no) 2000-10-25
DE69925721T2 (de) 2006-03-23
JP3374155B2 (ja) 2003-02-04
SK12992000A3 (sk) 2001-11-06
US6307059B1 (en) 2001-10-23
BG104767A (en) 2001-05-31
HU228309B1 (en) 2013-03-28
IN190979B (pt) 2003-09-06
CA2322540C (en) 2004-11-30
TR200101801T2 (tr) 2002-06-21
OA11482A (en) 2004-05-03
HUP0101094A2 (hu) 2001-08-28
BR9908472A (pt) 2000-12-05
SK285595B6 (sk) 2007-04-05
CZ301011B6 (cs) 2009-10-14
ID25901A (id) 2000-11-09
NZ506312A (en) 2002-04-26
IS5600A (is) 2000-08-22
CN1149192C (zh) 2004-05-12
EP1068182A1 (en) 2001-01-17
ATE297379T1 (de) 2005-06-15
JP2002505322A (ja) 2002-02-19
AP2000001890A0 (en) 2000-09-30
EA200000900A1 (ru) 2001-02-26
TR200101800T2 (tr) 2002-04-22
CA2322540A1 (en) 1999-09-10
ES2242382T3 (es) 2005-11-01
IL137828A0 (en) 2001-10-31
WO1999044991A1 (en) 1999-09-10
KR19990076521A (ko) 1999-10-15
AU2643399A (en) 1999-09-20
EA002499B1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR0008301B1 (pt) processo para a fabricaÇço de compostos, e, compostos.
PT1256584E (pt) Processo para a preparacao de adefovir-dipivoxil
BR9912109B1 (pt) compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
BR9907230B1 (pt) processo para a preparaÇço de um macrâmero.
BR9909925B1 (pt) derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina.
BR9912104B1 (pt) compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9908472B1 (pt) Processo para a preparação de um composto aminometil-pirrolidina-3-ona protegido, e, composto
BR9916187B1 (pt) processo para a preparação de 3-alcanoìla e 3-alquilindóis.
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
BR9711201A (pt) Processo para a prepara-ao de um composto
BR9917475B1 (pt) processo para a manufatura de compostos, e, modificação do processo.
BR9707811A (pt) Processo para preparação de um composto e composto
BR9807988B1 (pt) processo para a preparaÇço de um composto, e, composto.
BR9800557A (pt) Processo contínuo para preparação de 4-aminopiperidinas
PT1028960E (pt) Processo para a preparacao de derivados de tiazolidinodiona
BR9707173A (pt) Processo para a preparação de um composto e composto
BR9913938B1 (pt) processo para a preparação de óxido de etileno.
BR9805538B1 (pt) processo para a preparação de ferro-succinilcaseìna.
PT973769E (pt) Processo para a preparacao de eprosartan
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
PT970073E (pt) Processo para a preparacao de eprosartan
BR9813048B1 (pt) processo para a preparação de um composto.
PT1049723E (pt) Processo para o fabrico de inulina de chicoria

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B25A Requested transfer of rights approved

Free format text: LG LIFE SCIENCES LTD. (KR)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/03/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 04/03/2019

B15V Prolongation of time limit allowed